Cashu Markets
Cashu
Markets
  • Terminal
  • Stocks
  • Spotlight
  • News
Log inSign Up
  1. Stocks
  2. Healthcare
  3. NASDAQ
  4. GRAL

Market Cap: $2.99B

GI

GRAIL Inc.

GRAL
NASDAQUSD
OverviewNewsAnalyst ReportsFinancialsPolitician TradesInsider TradesExecutivePatentsEarnings Surprise
Cashu Markets
Cashu
Markets

By Cashu Markets. Providing market news, analysis, and research for investors worldwide.

Company

StocksAbout Cashu MarketsContact

Legal

Terms of ServicePrivacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Markets is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Markets is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Markets and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

$69.70
USD
+6.26(9.87%)
At close: Jul 30, 14:24 EDT

Recently from Cashu

GRAIL Inc.: Navigating Post-Trial Turmoil

GRAIL Inc.: Navigating Post-Trial Turmoil

GRAIL Inc. ( GRAL ) is drawing attention as the latest developments come into focus. GRAIL Inc. (GRAL) is facing a tumultuous period following the fallout from the NHS-Galleri trial results that sent…

Cashu Markets·7h ago
GRAIL Inc.: From Promise to Peril

GRAIL Inc.: From Promise to Peril

GRAIL Inc. ( GRAL ) is navigating a challenging landscape following the disappointing results from its NHS-Galleri trial, which has dramatically affected investor confidence, financial performance, an…

Cashu Markets·2d ago
GRAIL Inc.'s Path Through Crisis

GRAIL Inc.'s Path Through Crisis

GRAIL Inc. ( GRAL ) is drawing attention as the latest developments come into focus. GRAIL Inc. (GRAL) is currently facing a significant crisis following the failed NHS-Galleri trial. As one of the pi…

Cashu Markets·5d ago
GRAIL Inc.'s Tumultuous Future After Trial Failure

GRAIL Inc.'s Tumultuous Future After Trial Failure

GRAIL Inc. ( GRAL ) is navigating a precarious landscape following the disheartening results of its NHS-Galleri trial, which has dramatically impacted the company's financial standing and investor con…

Cashu Markets·7 days ago

Open

$68.71

Prev. Close

$64.42

High

$70.36

Low

$68.43

Company Profile

GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, its precision oncology portfolio consists of n RUO-targeted methylation-based platform that enables applications for disease prognostication, risk stratification, minimal residual disease detection, and recurrence and relapse monitoring. The company was incorporated in 2015 and is headquartered in Menlo Park, California.

CEOJoshua J. Ofman
SectorHealthcare
IndustryBiotechnology
Employees910
IPO DateJun 12, 2024
ExchangeNASDAQ
Exchange NameNASDAQ
CurrencyUSD
Headquarters & Contact
Address1525 O’Brien Drive
City / State / ZIPMenlo Park, CA, 94025
CountryUnited States
Phone833-694-2553
Websitehttp://www.grail.com